C-Rel polyclonal antibody

• Background:

  C-Rel contains an amino-terminal DNA-binding domain referred to as the REL homology domain (REH) and carboxy-terminal transactivation domains. The c-Rel protein is typically inhibited in unstimulated cells by IκBα and IκBβ. c-Rel expression is highest in hematopoietic cells with extensive research studies demonstrating its role in immune cell function and pathogenesis of disease.

• Structure Composition:

  Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.

• Product Name Alternative:

  REL

• Swiss Prot:

  Q04864

• Reactivity:

  Human

• Immunogen:

  A synthesized peptide derived from human c-Rel

• Conjugation:

  Unconjugated

• Applications:

  WB, IP

• Dilution:

  WB: 1/500-1/1000 IP: 1/20

• Purity:

  Affinity Purified

• Modification:

  Unmodified

• Molecular Weight:

  Calculated MW: 69 kDa; Observed MW: 69 kDa

• Storage Conditions:

  Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze-thaw cycles.

• Notes:

  For research use only, not for use in diagnostic procedure.

• Specificity:

  IgG

• Applications Notes:

  Western blot analysis of c-Rel in Daudi lysates using c-Rel antibody.

• Host or Source:

  Rabbit

• CAS Number:

  9007-83-4